Pharming Group N.V. (PHAR) Invested Capital (2019 - 2021)
Pharming (PHAR) has disclosed Invested Capital for 2 consecutive years, with $24.3 million as the latest value for Q4 2020.
- For the quarter ending Q4 2020, Invested Capital rose 22.95% year-over-year to $24.3 million, compared with a TTM value of $24.3 million through Dec 2023, down 44.85%, and an annual FY2020 reading of $23.2 million, up 16.37% over the prior year.
- Invested Capital was $24.3 million for Q4 2020 at Pharming, up from $19.7 million in the prior quarter.
- Across five years, Invested Capital topped out at $24.3 million in Q4 2020 and bottomed at $19.7 million in Q4 2019.